Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.
about
The great escape: viral strategies to counter BST-2/tetherinSpecies-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsVpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanismThe human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factorsThe role of BST-2/Tetherin in host protection and disease manifestationConformational changes induced by a single amino acid substitution in thetrans-membrane domain of Vpu: Implications for HIV-1 susceptibility to channel blocking drugsCounteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu geneNovel approaches to inhibiting HIV-1 replication.Lack of effect of cytoplasmic tail truncations on human immunodeficiency virus type 2 ROD env particle release activity.Regulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Foamy viruses are unconventional retrovirusesFunctional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.The roles of Pol and Env in the assembly pathway of human foamy virus.Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.Structural Basis for the Antiviral Activity of BST-2/Tetherin and Its Viral AntagonismThe human immunodeficiency virus (HIV) type 2 envelope protein is a functional complement to HIV type 1 Vpu that enhances particle release of heterologous retroviruses.A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulumUbiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain.Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.Viroporins customize host cells for efficient viral propagation.Human cellular restriction factors that target HIV-1 replication.Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 Isolates.Anti-tetherin activities in Vpu-expressing primate lentiviruses.Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1.Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells.Foamy virus envelope glycoprotein is sufficient for particle budding and release.Oligomerization of the human immunodeficiency virus type 1 (HIV-1) Vpu protein--a genetic, biochemical and biophysical analysis.Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus releaseRestriction of Retroviral Replication by Tetherin/BST-2.
P2860
Q21090506-1A53009C-AAD4-4A07-9CA7-61E017208CD1Q21559418-58442DA3-D7F5-45AE-B528-E4E0E5F1FE02Q24530181-47606AAF-6C34-433D-ACC3-03EAE000534AQ24619066-1DA70BBB-4965-44D1-BDAA-80533CD2D905Q24644811-C0EE40F7-F879-4D4D-83A5-9FF7781CEF4CQ24670601-BD0C6996-9D53-4485-AD3C-CBF74C2204CDQ26752737-C9A96F09-42DC-426E-A614-8A904A400F76Q27647751-CB51389A-F216-47A1-963F-91F69817C698Q28730542-DB8A9ECF-F7FD-4CCD-81C7-FEC1FE1EAA63Q33624690-6A96E983-F198-4C14-9375-74C7D2512315Q33639849-536BD463-FF0A-4841-B6F8-5374BD7B3205Q33640055-6D1EB6A8-9C90-4456-AC95-991DE51FB059Q33652656-00ED8E1F-AE2D-4CF5-88E3-52F4997BDE76Q33737672-CC7F9DCA-2E46-4DC7-A3F3-C0BCDAFBAECEQ33782618-D5B8C6C2-7120-473C-B99E-097A27C0E1A9Q33987373-1C10185F-EB66-40CD-B809-BDA2C9A3A771Q34492477-87D4B4F7-52E6-42AE-84C3-48C6C8927ACBQ35531194-3E1A7F11-8C91-4E9F-8ACB-DAD7982C8F6BQ35607295-A73E0295-A0AF-4B69-B517-6A06108BB153Q35873115-3E22E3C2-F7F1-4452-9ECE-A0B8249216CDQ35875985-30492140-861F-4175-9850-6884A952FF66Q35922462-3E74FFA8-3B31-4D72-90DC-8AADAF2E911AQ37115285-CC00E3C0-45F6-400E-8CCA-AEFB36037FF8Q37202578-4FAC0AFB-CD49-4A0B-A5E8-C99D47ED8920Q37382519-3DFAC730-BB24-4D4F-A81D-EB5B3224D84EQ37448301-A5DB0899-FF27-4F4C-A8C8-48C0D37DCD11Q39391944-384EF3B8-0BA2-479B-91A0-6B606A899DEDQ39577503-A1FB0731-7264-4645-86DD-2764F57D5B54Q39642301-00B75848-F4A4-4C22-90FF-47A9C73A9515Q39700302-EC5BE3C3-95EF-4662-84CD-3BBA1728015DQ40087952-3A8C50D5-3127-4CC2-B9DD-2C425B8756D0Q42133593-49564144-2F31-4FFA-9188-5998F919A0FBQ42234287-279A964C-1D4F-480D-AD95-B0E978AA05ED
P2860
Human immunodeficiency virus type 2 glycoprotein enhancement of particle budding: role of the cytoplasmic domain.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@ast
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@en
type
label
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@ast
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@en
prefLabel
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@ast
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus t ...... ole of the cytoplasmic domain.
@en
P2093
G D Ritter
G Yamshchikov
M J Mulligan
P2860
P304
P407
P577
1996-04-01T00:00:00Z